×

Biogen barreling down on Alzheimer's

3:33 PM ET Wed, 23 April 2014

CNBC's Meg Tirrell speaks with George Scangos, Biogen Idec CEO, about the drug maker's fight against MS and Alzheimer's. Scangos also comments on Valeant's bid for Alllergan.